ARSENAULT KAITLYN (Chief Financial Officer) received a stock award from SKYE BIOSCIENCE, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/6/2023ACC: 0001516551-23-000096
Officer· Chief Financial Officer
Since Oct 2021
+160.26K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
160.26K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+128.21K
Price / share
—
Trade value
—
% of position
222.9%
11/6/2023
57.53K→185.74K
Total
Net shares
+128.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/6/2023 | A · Award | +128.21K | — | — | 222.9% | 57.53K | 185.74K |
| Total | +128.21K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
32.05K shares
Shares
+32.05K
Strike price
3.50
Held after
45.44K
Exercisable
—
11/6/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock32.05K shares | 11/6/2023 | A · Award | +32.05K | 3.50 | — | 45.44K |